Compare FITB & MDLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FITB | MDLN |
|---|---|---|
| Founded | 1858 | 1966 |
| Country | United States | United States |
| Employees | 18676 | 45000 |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.2B | 37.4B |
| IPO Year | N/A | N/A |
| Metric | FITB | MDLN |
|---|---|---|
| Price | $49.89 | $36.71 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 16 | 23 |
| Target Price | ★ $55.13 | $50.48 |
| AVG Volume (30 Days) | 5.0M | ★ 9.4M |
| Earning Date | 04-17-2026 | 05-06-2026 |
| Dividend Yield | ★ 3.21% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $57.09 | $10.88 |
| Revenue Next Year | $7.06 | $7.69 |
| P/E Ratio | ★ $15.20 | $658.75 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $37.29 | $35.44 |
| 52 Week High | $55.44 | $50.88 |
| Indicator | FITB | MDLN |
|---|---|---|
| Relative Strength Index (RSI) | 55.68 | 36.25 |
| Support Level | $49.08 | $35.50 |
| Resistance Level | $50.86 | $46.29 |
| Average True Range (ATR) | 0.90 | 1.48 |
| MACD | 0.14 | -0.03 |
| Stochastic Oscillator | 83.02 | 29.88 |
Fifth Third Bancorp is a midsize regional bank in the US, with total assets of around $300 billion as of March 2026. The bank closed its acquisition of Comercia in February 2026. Headquartered in Cincinnati, Ohio, Fifth Third has a strong presence in the US Midwest and is currently expanding in the US Southeast. The bank provides a diversified set of financial services in retail banking, commercial banking, card and Treasury management, wealth and asset management, and capital markets.
Medline is the largest medical-surgical products and supply chain solutions provider in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.